QuidelOrtho Earnings: Key Expectations
QuidelOrtho (NASDAQ: QDEL), a healthcare diagnostics firm, will release its financial results tomorrow. Here's what to anticipate:
Q4 FY2023 Estimates
Analysts forecast QDEL's revenue to decrease 6% YoY to $698.4 million, an improvement over last year's 14.3% decline. Adjusted EPS is projected at $0.58 per share.
Historical Performance
QuidelOrtho has consistently exceeded revenue estimates, missing only once in the past two years by an average of 6.6%.
Peer Comparison
Hologic (HOLX) reported flat YoY revenue, meeting expectations, while Intuitive Surgical (ISRG) posted a 25.2% revenue increase, surpassing estimates by 6.5%.
Market Outlook
Shares in the healthcare equipment and supplies industry have remained stable ahead of earnings, with QuidelOrtho experiencing a 3.9% decline. Its average analyst price target stands at $51.14 (versus the current share price of $42.89).
Disclaimer: This analysis is for informational purposes only and does not constitute investment advice.